Tag archive for ‘Eyal Desheh’

Teva secures $34 billion financing for Allergan acquisition

  Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has entered into commitment letters relating to its pending acquisition of Allergan’s generic pharmaceuticals business with Bank of America More...

Shiri Habib-Valdhorn On Thursday, May 14th, 2015

Three way takeover battle- Teva: We can close Mylan deal in 2015

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) CFO Eyal Desheh remains upbeat about Teva’s attempts to buy Mylan N.V. (Nasdaq: MYL). At the same time, Mylan continues to oppose the takeover More...

Shiri Habib-Valdhorn On Wednesday, June 11th, 2014

Teva CFO eyes small US acquisitions

– Eyal Desheh: There are many small US companies developing complex generic products. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) is eying small acquisitions of More...

CFO Eyal Desheh, TEVA
Clive Minchom On Wednesday, January 15th, 2014

Teva Acting CEO Eyal Desheh : We Are Committed to Reducing Costs by $2 Billion

– Acting CEO Eyal Desheh: We are committed to reducing costs by $2 billion and moving production from the US to Europe and Asia. – – The share price of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; More...

Yoel Bermant On Thursday, January 9th, 2014

Teva Names Erez Vigodman as President and CEO

– – Teva Pharmaceutical Industries Ltd (NYSE:TEVA) today announced that Erez Vigodman, 54, has been appointed President and Chief Executive Officer, effective February 11, 2014. Mr. Vigodman More...

Clive Minchom On Sunday, December 22nd, 2013

Israeli 3D Printer Co Stratasys Share Price Up 250% Since Merger

– Some of the company’s Israeli shareholders having been cashing in on the share’s record price. – David Reis CEO Stratasys – The share price of 3D printer company Stratasys Inc. (Nasdaq: SSYS) More...

Wordpress site Developed by Fixing WordPress Problems